Why It Matters
This indicates stronger-than-expected global demand for Moderna's vaccines, potentially boosting the company's revenue and market share in key international markets.
Key Intelligence
- ■Moderna reported strong sales performance for its vaccines.
- ■These robust sales were primarily observed outside the United States.
- ■The company's international vaccine sales significantly surpassed analyst estimates.